Official Site of The State of New Jersey
Healthy New Jersey
Treatment
Currently, there is no treatment approved specifically for mpox. Most people with mpox recover with supportive care and pain management . However, some individuals, especially those who are immunocompromised or have certain underlying skin conditions like eczema, may benefit from medications that are available only to health care providers through health departments or the CDC.
What to Do if You Have Mpox Symptoms
If you experience symptoms of mpox, it’s important to act quickly, even if you’ve been vaccinated:
Contact a Health Care Provider
Visit your health care provider to discuss your symptoms, see if you need to be tested, and to discuss potential treatment options.
Access Low-Cost Medical Care
If you don’t have a health care provider, Federally Qualified Health Centers (FQHCs) across the state offer low-cost care.
TPOXX (Tecovirimat)
TPOXX is an experimental (investigational) antiviral drug. Recent results of a clinical trial (STOMP trial) found that tecovirimat was safe but did not reduce the time to resolution of lesions nor have an effect on pain among adults with mild to moderate clade II mpox and a low risk of developing severe disease. More studies are needed to determine the role of tecovirimat in the treatment of mpox for patients with severe immunocompromise.
At this time, tecovirimat is only available through the EA-IND protocol via health care providers.
Health Care Provider Information
- Providers can find detailed guidance on mpox treatment and TPOXX eligibility by visiting CDC's clinical treatment of mpox website .
- Health care providers may request tecovirimat from NJDOH for patients that meet criteria under CDC’s EA-IND protocol through the following link: http://healthsurveys.nj.gov/NoviSurvey/n/TPOXX.aspx
- Health care providers that have any issues submitting a request should email vax.operations@doh.nj.gov.